VISION Data Report 2022

VII. Metastasis The Metastasis section provides insight into metastasis for patients whose information and experiences have been shared with VISION. The data is divided into three categories: Diagnosis, Symptoms and Treatment. Diagnosis At the time of diagnosis with metastatic ocular melanoma, where was the metastasis detected? Check all that apply.*

Pictured here (from L to R): Dr. Sara Selig, Dr. Thomas Olencki and Dr. Esther Damaser (founding member of the CURE OM Patient and Family Steering Committee).

60%

The 24% of patients who responded “Other” reported:

40% Peritoneum

40% Pancreas 20% Right adrenal gland

24%

10%

5%

LYMPH NODES 1%

“The VISION Registry will accelerate our own research efforts and also allow for new collaborations that wouldn’t have been possible before. OM patients have always been the most important member of their own treatment team, and now they are impacting life-saving research all over the world.” — Dr. Marlana Orloff, Clinician/Researcher

BRAIN

LIVER

OTHER

LUNG

Out of the 123 patients who completed surveys, 20 reported having metastases. * Please note: the questions in this section are answered from the time point of the initial diagnosis of primary ocular melanoma.

2022 VISION Registry Data Report

42

Made with FlippingBook Ebook Creator